TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: Lack of correlation with human papillomavirus status

Journal of Investigative Dermatology

Volumn 118, Issue 6, 2002, Pages 1026-1031

  Cairey Remonnay, Sandrine ^a,b   Humbey, Olivier ^a   Mougin, Christiane ^a   Algros, Marie P ^b   Mauny, Frédéric ^b   Kanitakis, Jean ^b   Euvrard, Sylvie ^b   Laurent, René ^b   Aubin, François ^a,b  

^a Department of Dermatology   (France)

^b Department of Dermatology ^*  (France)

Author keywords

Human papillomavirus; p53 polymorphism; Renal transplant recipient; Squamous cell carcinoma

Indexed keywords

ARGININE; VIRUS DNA;

ADULT; AGED; ALLELE; ARTICLE; BENIGN TUMOR; CANCER RISK; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; DNA POLYMORPHISM; EXON; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; RISK FACTOR; SKIN CARCINOMA; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; VIRUS DETECTION; VIRUS TYPING;

EID: 0036280715     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.01787.x     Document Type: Article

References (38)

1. Renal transplantation and skin diseases: Review of the literature and results of a 5-year follow-up of 285 patients
2. Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: A need for screening?
3. Is p53 polymorphism maintained by natural selection?
4. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients
5. Skin lesions in renal transplant patients after 10-23 years of immunosuppressive therapy
6. HPV infections and immunosuppression
7. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia
8. Cancer, warts, and sunshine in renal transplant recipients: A case-control study
9. Treasure hunt for human papillomaviruses in non melanoma skin cancers
10. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated non-melanoma skin cancers in immunocompetent hosts
11. CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients
12. Analysis of human papillomavirus type 16, E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis
13. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients
14. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin
15. No association between p53 codon 72 polymorphism and the risk of squamous cell carcinoma of the head and neck
16. Skin cancer in transplant recipients
17. p53 polymorphism and risk of cervical cancer
18. Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient: Detection of a new sequence related to epidermodysplasia verruciformis associated types
19. Role for the p53 homologue p73 in E2F-1-induced apoptosis
20. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage
21. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: A clinical study to assess risk factors for keratotic skin lesions and skin cancers
22. Incidence of skin cancer in 5356 patients following organ transplantation
23. A common E2F- 1 and p73 pathway mediates cell death induced by TCR activation
24. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses
25. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
26. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation
27. P53 codon 72 polymorphism and susceptibility to skin cancer after renal transplantation
28. Primary structure polymorphism at amino acid residue 72 of human p53
29. p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status
30. P53 codon 72 polymorphism and human papillomavirus associated skin cancer
31. p73 is over-expressed in vulval cancer principally as the delta 2 isoform
32. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins
33. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss
34. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by hybrid capture II and polymerase chain reaction
35. The E6 oncoprotein encoded by human papilloma virus types 16 and 18 promotes the degradation of p53
36. Human papillomavirus infections in non melanoma skin cancers from renal transplant recipients and non immunosuppressed patients
37. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
38. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients